The 2 analysts offering 12-month price forecasts for Minerva Neurosciences Inc have a median target of 34.50, with a high estimate of 48.00 and a low estimate of 21.00. The median estimate represents a +951.83% increase from the last price of 3.28.
The current consensus among 3 polled investment analysts is to Buy stock in Minerva Neurosciences Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.49
Reporting Date Nov 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.